Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
VNDA
— Vanda Pharmaceuticals Inc.
NASDAQ
FULL STOCK PAGE →
Q2 2026 Earnings Call Summary
AUG 5, 2026
REVENUE
$50.5M
-2.3%
NET MARGIN
-123.7%
-29.8 PTS
EPS
-$1.04
-26.8%
FREE CASH FLOW
-$81.7M
-62.0%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 4
OLDER CALL →